GEODE CAPITAL MANAGEMENT, LLC
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1214717
BOSTON, MA
Position in DNTH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$122,678,774
+$45,790,348 QoQ
Shares Held
1,258,502
+37.4% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 269 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. DNTH ranks #41 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in DNTH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,678,774 | 1,258,502 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $76,888,426 | 916,211 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,885,075 | 676,658 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $21,107,929 | 536,415 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $9,033,686 | 484,900 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $9,378,706 | 517,018 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,600,533 | 486,263 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $13,282,612 | 485,121 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,912,049 | 498,920 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,232,000 | 74,400 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $469,861 | 45,179 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $360,081 | 26,341 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 MGTA | — | 357,690 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 MGTA | — | 357,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 MGTA | — | 357,690 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 MGTA | — | 350,436 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 MGTA | — | 343,870 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 MGTA | — | 593,289 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 MGTA | — | 551,938 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 MGTA | — | 528,274 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 MGTA | — | 503,191 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 MGTA | — | 403,798 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 MGTA | — | 287,894 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 MGTA | — | 288,431 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 MGTA | — | 279,921 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 MGTA | — | 271,035 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||